sevoflurane has been researched along with Diathesis in 11 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propofol infusion syndrome is a rare condition that mainly affects critically ill patients who receive high doses of this hypnotic for a long time." | 7.96 | Propofol infusion syndrome; are high doses always required? ( Boliart de San Félix, Y; Fernández Morales, M; Sánchez Royo, E; Subirà González, A; Vila Lolo, C, 2020) |
| "Propofol infusion syndrome is a rare condition that mainly affects critically ill patients who receive high doses of this hypnotic for a long time." | 3.96 | Propofol infusion syndrome; are high doses always required? ( Boliart de San Félix, Y; Fernández Morales, M; Sánchez Royo, E; Subirà González, A; Vila Lolo, C, 2020) |
| "Williams-Beuren syndrome is the clinical manifestation of a congenital genetic disorder in the elastin gene, among others." | 1.48 | Cardiac arrest related to anaesthesia in Williams-Beuren syndrome. ( Castro Parga, L; Durán la Fuente, P; Gónzalez Rocafort, A; Lucena Delgado, J; Reinoso Barbero, F; Sanabria Carretero, P, 2018) |
| "Sevoflurane is a known triggering agent of malignant hyperthermia (MH)." | 1.39 | Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility. ( Heiderich, S; Johannsen, S; Klingler, W; Roewer, N; Schneiderbanger, D; Schuster, F, 2013) |
| "When preparing the Fabius CE for the malignant hyperthermia susceptible patient, remove the vaporiser, replace the disposable tubing, the reservoir bag and the CO2 absorber." | 1.38 | Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia. ( O'Donoghue, R; O'Kelly, P; O'Rourke, J; Shanahan, H; Synnott, A, 2012) |
| "To diagnose malignant hyperthermia (MH) susceptibility, muscle bundles are exposed to halothane and caffeine." | 1.37 | Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study. ( Anetseder, M; Hartung, E; Metterlein, T; Roewer, N; Schuster, F, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Subirà González, A | 1 |
| Fernández Morales, M | 1 |
| Sánchez Royo, E | 1 |
| Boliart de San Félix, Y | 1 |
| Vila Lolo, C | 1 |
| Gonzalez, A | 1 |
| Iles, TL | 1 |
| Iaizzo, PA | 1 |
| Bandschapp, O | 1 |
| Lucena Delgado, J | 1 |
| Sanabria Carretero, P | 1 |
| Durán la Fuente, P | 1 |
| Gónzalez Rocafort, A | 1 |
| Castro Parga, L | 1 |
| Reinoso Barbero, F | 1 |
| Johannsen, S | 1 |
| Klingler, W | 1 |
| Schneiderbanger, D | 1 |
| Heiderich, S | 1 |
| Roewer, N | 2 |
| Schuster, F | 2 |
| Gunter, JB | 1 |
| Ball, J | 1 |
| Than-Win, S | 1 |
| Metterlein, T | 1 |
| Hartung, E | 1 |
| Anetseder, M | 1 |
| Shanahan, H | 1 |
| O'Donoghue, R | 1 |
| O'Kelly, P | 1 |
| Synnott, A | 1 |
| O'Rourke, J | 2 |
| Sarti, A | 1 |
| Busoni, P | 1 |
| Dell'Oste, C | 1 |
| Bussolin, L | 1 |
| Prinzhausen, H | 1 |
| Crawford, MW | 1 |
| Petroz, GC | 1 |
| Ducart, A | 1 |
| Adnet, P | 1 |
| Renaud, B | 1 |
| Riou, B | 1 |
| Krivosic-Horber, R | 1 |
| Goresky, GV | 1 |
| Cox, RG | 1 |
1 trial available for sevoflurane and Diathesis
| Article | Year |
|---|---|
Incidence of vomiting in susceptible children under regional analgesia with two different anaesthetic techniques.
Topics: Anesthesia, Conduction; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenous | 2004 |
10 other studies available for sevoflurane and Diathesis
| Article | Year |
|---|---|
Propofol infusion syndrome; are high doses always required?
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine; Chemical | 2020 |
Impact of statin intake on malignant hyperthermia: an in vitro and in vivo swine study.
Topics: Animals; Contracture; Disease Susceptibility; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Malign | 2020 |
Cardiac arrest related to anaesthesia in Williams-Beuren syndrome.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Aortic Stenosis, Supravalvular; Arteries; Bradycard | 2018 |
Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
Topics: Anesthetics, Inhalation; Biopsy; Disease Susceptibility; Dose-Response Relationship, Drug; Genetic P | 2013 |
Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
Topics: Anesthesiology; Anesthetics, Inhalation; Disease Susceptibility; Equipment Contamination; Humans; Ma | 2008 |
Sevoflurane as a potential replacement for halothane in diagnostic testing for malignant hyperthermia susceptibility: results of a preliminary study.
Topics: Anesthetics, Inhalation; Caffeine; Central Nervous System Stimulants; Disease Susceptibility; Dose-R | 2011 |
Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Decontamination; Disease Susceptibility; Disposable | 2012 |
Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
Topics: Anesthesiology; Anesthetics, Inhalation; Disease Susceptibility; Equipment Contamination; Humans; Is | 2006 |
Malignant hyperthermia during sevoflurane administration.
Topics: Adult; Anesthetics; Caffeine; Disease Susceptibility; Ethers; Female; Halothane; Humans; Malignant H | 1995 |
Inhalation anesthetics and Duchenne's muscular dystrophy.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Contraindications; Disease Susceptibility; Haloth | 1999 |